RxDoctor Payments Data

M Lisa Attebery, DO

Surgery · Rehoboth Beach, DENPI 1649385626

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $21,438 of the $21,977 with a category attached, or 97.5%. Medtronic accounts for 97.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $19,292 and has fallen 88.1% since, to $2,297 in 2025. Among surgery clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,977in general payments, 2019–2025

Across 25 payments — averaging $879.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$21K
  • TELA Bio, Inc.$182
  • AbbVie$165
  • Endomagnetics Ltd$76
  • Baxter Healthcare$30
  • Bard Peripheral Vascular, Inc.$28
  • plus $59 from 3 others
$27,875in research payments, 2019–2025

Across 11 payments — averaging $2534.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$28K

What the payments were for

  • Consulting fees$21,43898%
  • Food & beverage$5402%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,977 in reported general payments places this provider in the 95th percentile of 89 surgery providers in Delaware.

See all surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$44,516
Medicare patients
72
Services billed
219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin26$82
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$70

Paid to pharmacies, not to this prescriber.

Other surgery in Rehoboth Beach

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →